Recent

% | $
Quotes you view appear here for quick access.

Immune Pharmaceuticals, Inc. Message Board

  • synergykjs synergykjs Mar 1, 2007 7:45 PM Flag

    What I heard in the CC

    a very confident Jack Talley, upbeat and to the point

    the mention of initiating discussions with other pharma companies for collaboration

    2407 expected to have significant sales potential

    AGGRESSIVELY persuing Ceplene

    Still focus on NP1 (sales of this could be very large imo)

    Azixa VERY significant market potential
    escalating double digit royalties
    (yes, I am very excited about this)

    I remember someone posting here that Azixa could reach 1.5 billion in annual revs = 150m+ annually...cha ching!

    Myriad stated that Azixa could hit the market in 2008!!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Thanks for your updates, it really sounds good, I think one of the next major news is about Azixa with Myriad. I did call Epicept and Myriad a few months ago about the royalties, both of them have clearly told me that the royalties will be in a low single digit millions payment. Now the royalties are escalating to double digit millions, as Azixa is very promising as per last conference call from Myriad I think there was some extended negotiations between Myriad and Epicept about the royalties agreement, that could be one of the reason why there was a delay in starting the phase 2 by Myriad which should have started last fall 2006. That's a very good sign and we will have news about Azixa phase 2 and royalties payment very soon. jmo and glta

 
IMNP
1.27-0.01(-0.78%)Sep 4 4:00 PMEDT